J 2019

Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes

JANKŮ, Petr, Marian KACEROVSKY, Barbora ZEDNIKOVA, Ctirad ANDRYS, Martina KOLACKOVA et. al.

Základní údaje

Originální název

Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes

Autoři

JANKŮ, Petr (203 Česká republika, domácí), Marian KACEROVSKY (203 Česká republika, garant), Barbora ZEDNIKOVA (203 Česká republika), Ctirad ANDRYS (203 Česká republika), Martina KOLACKOVA (203 Česká republika), Marcela DRAHOSOVA (203 Česká republika), Lenka PLISKOVA (203 Česká republika), Helena ZEMLICKOVA (203 Česká republika), Romana GERYCHOVÁ (203 Česká republika, domácí), Ondrej SIMETKA (203 Česká republika), Petr MATLAK (203 Česká republika), Bo JACOBSSON (752 Švédsko) a Ivana MUSILOVA (203 Česká republika)

Vydání

Fetal Diagnosis and Therapy, Basel, Karger, 2019, 1015-3837

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30214 Obstetrics and gynaecology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.095

Kód RIV

RIV/00216224:14110/19:00112965

Organizační jednotka

Lékařská fakulta

UT WoS

000507387300007

Klíčová slova anglicky

Inflammation; Microorganism; Pattern recognition receptor; Preterm birth

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 11. 5. 2020 13:30, Mgr. Tereza Miškechová

Anotace

V originále

Problem: To determine the changes of pentraxin 3 (PTX3) level in noninvasively obtained cervical fluid samples from women with preterm prelabor rupture of membranes (PPROM) based on the presence of microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI), and intra-amniotic infection (the presence of both MIAC and IAI). Methods of Study: A total of 160 women with PPROM were included. Cervical fluid samples were obtained using a Dacron polyester swab and amniotic fluid samples were obtained by transabdominal amniocentesis. Cervical fluid PTX3 levels were assessed using enzyme-linked immunosorbent assay. Results: PTX3 was found in all the cervical fluid samples and its levels were higher in women with MIAC, IAI, and intra-amniotic infection than in women without these conditions. When the women were categorized into four subgroups based on the presence of MIAC and/or IAI, women with intra-amniotic infection had higher cervical fluid PTX3 levels than those with sterile IAI (IAI alone), colonization (MIAC alone), or no MIAC or IAI. A cervical fluid PTX3 level of 11 ng/mL was the best value for identifying the presence of intra-amniotic infection in women with PPROM. Conclusions: PTX3 is a constituent of cervical fluid of women with PPROM. Cervical fluid PTX3 level reflects the situation in the intra-amniotic compartments of women with PPROM. Cervical fluid PTX3 is a potential marker for the noninvasive identification of intra-amniotic infection in PPROM.